5401 - 5425 of 9140 Results
Title
Year
-
OPENTitle: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 119Issue #:Start Page: 105954End Page: 105954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903276/pdf/nihms-1966735.pdfCitation Count: 3
- Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations2026OPENTitle: Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitationsJournal Name: Acta Pharmaceutica Sinica BPublisher: Elsevier BVVol: 16Issue #: 5Start Page: 2645End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.apsb.2026.03.031Best OA location URL: https://doi.org/10.1016/j.apsb.2026.03.031Citation Count: 0
-
OPENTitle: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational researchJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100339End Page: 100339Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100339Citation Count: 0
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
-
OPENTitle: Sacral nerve stimulation improves gait in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 1075End Page: 1076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074Best OA location URL: https://doaj.org/article/1a3d778a5f164f45882a79a2adfcbf97Citation Count: 0
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page: 9409363End Page: 9409363Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 93
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 81
-
OPENTitle: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal TinnitusJournal Name: BioMed Research InternationalPublisher: WileyVol: 2015Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2015/569052Best OA location URL: https://downloads.hindawi.com/journals/bmri/2015/569052.pdfCitation Count: 26
-
OPENTitle: A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-SynucleinJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 4Start Page: 1107End Page: 1119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-017-0544-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-017-0544-9.pdfCitation Count: 60
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 2
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016OPENTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 23
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia2013RESTRICTEDTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 47
-
OPENTitle: Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease riskJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01040End Page: e01040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01040Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01040Citation Count: 0
-
OPENTitle: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stageJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 213Issue #:Start Page: 107018End Page: 107018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107018Citation Count: 2
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 7
-
OPENTitle: PINK 1 autophosphorylation is required for ubiquitin recognitionJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201744981Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981Citation Count: 117
-
OPENTitle: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 179End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27223Citation Count: 40
- TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice2007OPENTitle: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 26Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012Best OA location URL: https://doaj.org/article/e30977e5fbe84409a2cee00917b4ca29Citation Count: 182
- An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates2018RESTRICTEDTitle: An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 58
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism2019RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 40
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial2010RESTRICTEDTitle: Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 9Issue #: 12Start Page: 1164End Page: 1172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(10)70254-4Citation Count: 681
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile2008RESTRICTEDTitle: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 16Start Page: 2398End Page: 2403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22341Citation Count: 251
-
OPENTitle: Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulationJournal Name: Journal of Vascular SurgeryPublisher: Elsevier BVVol: 75Issue #: 1Start Page: 223End Page: 228Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jvs.2021.07.238Best OA location URL: http://www.jvascsurg.org/article/S0741521421019819/pdfCitation Count: 12
-
OPENTitle: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in SolutionJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 17Issue #: 13Start Page: 12325End Page: 12335Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.3c01393Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c01393Citation Count: 51
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1